DK458480A - Dna, recombinant plasmid og mikroorganisme indeholdende dette samt fremgangsmaader til fremstilling deraf - Google Patents

Dna, recombinant plasmid og mikroorganisme indeholdende dette samt fremgangsmaader til fremstilling deraf

Info

Publication number
DK458480A
DK458480A DK458480A DK458480A DK458480A DK 458480 A DK458480 A DK 458480A DK 458480 A DK458480 A DK 458480A DK 458480 A DK458480 A DK 458480A DK 458480 A DK458480 A DK 458480A
Authority
DK
Denmark
Prior art keywords
dna
procedures
production
recombinant plasmid
microorganism containing
Prior art date
Application number
DK458480A
Other languages
English (en)
Inventor
H Sugano
M Muramatsu
T Taniguchi
Original Assignee
Juridical Found Japanese
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP13928979A external-priority patent/JPS5663996A/ja
Priority claimed from JP3393180A external-priority patent/JPS56131598A/ja
Application filed by Juridical Found Japanese filed Critical Juridical Found Japanese
Publication of DK458480A publication Critical patent/DK458480A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK458480A 1979-10-30 1980-10-29 Dna, recombinant plasmid og mikroorganisme indeholdende dette samt fremgangsmaader til fremstilling deraf DK458480A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13928979A JPS5663996A (en) 1979-10-30 1979-10-30 Novel recombinant having gene complementary to human interferon messenger rna
JP3393180A JPS56131598A (en) 1980-03-19 1980-03-19 Novel recombinant plasmid having gene of human fibroblastic interferon messenger rna

Publications (1)

Publication Number Publication Date
DK458480A true DK458480A (da) 1981-05-01

Family

ID=26372701

Family Applications (1)

Application Number Title Priority Date Filing Date
DK458480A DK458480A (da) 1979-10-30 1980-10-29 Dna, recombinant plasmid og mikroorganisme indeholdende dette samt fremgangsmaader til fremstilling deraf

Country Status (8)

Country Link
EP (1) EP0028033B1 (da)
AU (1) AU538665B2 (da)
CA (1) CA1341563C (da)
DE (1) DE3071435D1 (da)
DK (1) DK458480A (da)
ES (3) ES496426A0 (da)
IL (1) IL61366A (da)
NO (1) NO158950C (da)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554513A (en) * 1979-11-21 1996-09-10 Yeda Research & Development Co. Ltd. Production of recombinant human interferon-beta2
US5510472A (en) * 1979-11-21 1996-04-23 Yeda Research And Development Co. Ltd. Production of recombinant human interferon-beta2
US6835557B1 (en) 1980-01-08 2004-12-28 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing human interferon-like polypeptides
CY1346A (en) * 1980-01-08 1987-01-16 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing human interferon-like polypeptides
DK33181A (da) * 1980-02-06 1981-08-07 Searle & Co Fremgangsmaade til fremstilling af et interferonlignende protein
DE3005843A1 (de) * 1980-02-16 1981-09-10 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
DE3177213D1 (de) 1980-04-03 1990-10-18 Biogen Inc Dns-sequenzen, rekombinante dns-molekuele und verfahren zur herstellung von dem menschlichen fibroblast-interferon.
FR2490675B1 (fr) * 1980-09-25 1985-11-15 Genentech Inc Production microbienne d'interferon de fibroplaste humain
DE3280127D1 (de) * 1981-03-27 1990-04-12 Ici Plc Genetisch modifizierte mikroorganismen.
IL65475A0 (en) * 1981-04-17 1982-07-30 Meloy Lab Production of immune interferon and its mrna
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
US5582824A (en) * 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
US4450103A (en) * 1982-03-01 1984-05-22 Cetus Corporation Process for recovering human IFN-β from a transformed microorganism
US5827694A (en) * 1982-03-08 1998-10-27 Genentech, Inc. DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
DE3220116A1 (de) * 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
US4588585A (en) * 1982-10-19 1986-05-13 Cetus Corporation Human recombinant cysteine depleted interferon-β muteins
US4737462A (en) * 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US5831023A (en) * 1982-11-01 1998-11-03 Genentech, Inc. Recombinant animal interferon polypeptides
US4518584A (en) * 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
US4855238A (en) 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
US5425940A (en) * 1986-04-09 1995-06-20 Cetus Oncology Corporation Combination therapy using interleukin-2 and tumor necrosis factor
ES2074420T3 (es) 1986-04-15 1995-09-16 Ciba Geigy Ag Anticuerpos monoclonales contra proteina humana inducida por interferon en forma pura y kits de ensayo que contienen dichos anticuerpos.
US4961969A (en) * 1987-05-11 1990-10-09 Cetus Corporation Process for recovering microbially produced interferon-β
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
GB9506051D0 (en) 1995-03-24 1995-05-10 Univ Singapore Gene expression
DK1017413T4 (da) 1997-09-23 2008-03-25 Rentschler Biotech Gmbh Flydende formulering af interferon-beta
EP1274720A4 (en) 2000-04-12 2004-08-18 Human Genome Sciences Inc FUSION PROTEINS CONTAINING ALBUMIN
US6887462B2 (en) 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
PT1463751E (pt) 2001-12-21 2013-08-26 Human Genome Sciences Inc Proteínas de fusão de albumina
CA2513213C (en) 2003-01-22 2013-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
DK3321359T3 (da) 2005-04-11 2021-03-08 Horizon Pharma Rheumatology Llc Variante former af uratoxidase og anvendelse deraf
WO2008051178A2 (en) 2006-04-12 2008-05-02 Savient Pharmaceuticals, Inc. Purification of proteins with cationic surfactant
US8273561B2 (en) 2007-10-05 2012-09-25 Nuron Biotech, Inc. High pressure treatment of aggregated interferons
RU2535038C2 (ru) 2009-06-25 2014-12-10 Криэлта Фармасьютикалз ЭлЭлСи Способы и наборы для прогнозирования риска инфузионных реакций и опосредованной антителами потери ответа при терапии пэгилированной уриказой с помощью мониторинга содержания мочевой кислоты в сыворотке крови
DE102009032179A1 (de) 2009-07-07 2011-01-13 Biogenerix Ag Verfahren zur Reinigung von Interferon beta
US20200237881A1 (en) 2019-01-30 2020-07-30 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
EP3538135A4 (en) 2016-11-11 2020-07-29 Horizon Pharma Rheumatology LLC POLYTHERAPIES OF PREDNISONE AND URICASE MOLECULES AND THEIR USES
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers

Also Published As

Publication number Publication date
ES8303530A1 (es) 1983-02-01
ES8203102A1 (es) 1982-02-16
EP0028033A3 (en) 1981-08-19
EP0028033A2 (en) 1981-05-06
EP0028033B1 (en) 1986-02-19
ES507596A0 (es) 1983-02-01
IL61366A0 (en) 1980-12-31
AU6376280A (en) 1981-05-07
NO803230L (no) 1981-05-04
DE3071435D1 (en) 1986-03-27
NO158950B (no) 1988-08-08
IL61366A (en) 1983-11-30
NO158950C (no) 1988-11-16
ES8303529A1 (es) 1983-02-01
CA1341563C (en) 2007-12-04
ES496426A0 (es) 1982-02-16
ES507595A0 (es) 1983-02-01
AU538665B2 (en) 1984-08-23

Similar Documents

Publication Publication Date Title
NO803230L (no) Dna, rekombinant plasmid og mikroorganisme inneholdende dette samt fremgangsmaater til fremstilling derav
NO171364C (no) N-aryl-3-aryl-4,5-dihydro-1h-pyrazol-1-karboksamider og fremgangsmaate til fremstilling derav, samt insektmiddel sominneholder karboksamidet
EP0177568A4 (en) RECOMBINANT DNA MOLECULES.
DK162099C (da) Antibiotika, fremgangsmaade til fremstilling deraf samt mikroorganismer til anvendelse ved fremgangsmaaden
DK110885D0 (da) Nucleinsyre-proteinkonjugater, disses anvendelse samt fremgangsmaade til fremstilling heraf
EP0020251A3 (en) Dna transfer vector, host transformed with it, vaccine, and their production
DK58985A (da) Nukleinsyrereagenser, fremgangsmaade til fremstilling deraf og anvendelse deraf
DK54382A (da) 1,3-dihydro-6-methyl-7-hydroxy-furo-(3,4-c)-pyridiner samt fremgangsmaade til fremstilling deraf
NO862545D0 (no) Vannbasert polymermateriale og fremgangsmaate til fremstilling, samt anvendelse derav.
FI823356A0 (fi) Dna, rekombinations-dna, dessa innehaollande vaerdar, polypeptider samt foerfaranden foer deras framstaellning
DK586685A (da) Antitumor-aktivt stof, fremgangsmaade til dets fremstilling, laegemiddel indeholdende stoffet, gen kodende for stoffet, vektor indeholdende genet samt rekombinant mikroorganisme
DK568587D0 (da) Dna fragmenter indeholdende alkalisk cellulasegen, rekombinante plasmider indeholdende disse dna fregmenter og rekombinante mikroorganismer
IT8020791A0 (it) Elettrodo biomedico.
DK310186A (da) N-alkylphenyl-maleimider og termohaerdelige formstof-blandinger indeholdende saadanne, samt fremgangsmaade til fremstilling deraf
FI870147A0 (fi) Mikrobiologisk framstaellningsmetod.
NL930010I2 (nl) Recombinant DNA-moleculen en de produktie daarvan.
FR2564854B1 (fr) Photobioreacteur.
DK589483A (da) Mikrobiel loebe, fremgangsmaade til fremstilling deraf og plasmider til anvendelse ved fremgangsmaaden
NO853400L (no) Polypeptidvaksiner.
FI900320A0 (fi) Gastaett, vaermestabilt, flersiktat material samt saett att framstaella detsamma.
NO833542L (no) Nytt dna og rekombinantplasmid inneholdende samme
IT8021959A0 (it) Gruppo cilindro-pistone differenziale per comandi in genere.
NO885781D0 (no) For-raamateriale og fremgangsmaate til fremstilling derav, samt forblanding inneholdende for-raamaterialet, og fremgangsmaate til fremstilling derav.
DK538386A (da) Streptomycin-sensitivt gen, plasmidvektor indeholdende dette samt mikroorganisme indeholdende vektoren
IT8022450A0 (it) Vetro cavo e procedimento per lasua realizzazione.

Legal Events

Date Code Title Description
ARF Application refused